
"Insights from Immunocompromised Patients Shed Light on Chronic Covid"
New research published in Science Translational Medicine examines the persistence of Covid in immunocompromised patients, revealing varying levels of risk for chronic infection. The study found that patients with severe immunosuppression, such as those with malignancies or bone marrow transplants, faced challenges in clearing the virus, leading to higher rates of viral evolution and impacting treatment efficacy. The findings underscore the need to identify effective treatment strategies for persistently infected patients and address the public health concern of potential viral variants emerging from these cases. Immunocompromised individuals continue to face heightened risks and challenges as the pandemic persists, despite the broader perception that it is largely over.


